Myeloid and Mast Cell Progenitors Are Elevated in Atopic Dermatitis
- PMID: 40697360
- PMCID: PMC12280991
- DOI: 10.1016/j.xjidi.2025.100390
Myeloid and Mast Cell Progenitors Are Elevated in Atopic Dermatitis
Abstract
Chronic spontaneous urticaria and atopic dermatitis (AD) are chronic skin disorders characterized by itch. Although mast cells play an integral role in the pathogenesis of chronic spontaneous urticaria, their role in AD is unclear, having a contributory role in a disease largely driven by T helper 2 polarization. Despite this, the role of mast cells in AD is important, given their release of proinflammatory mediators. Recently, myeloid and mast cell progenitors were identified as potential biomarkers for treatment response in chronic spontaneous urticaria. These Lin-CD117+CD34+FceRI+ cells appear to have increased egress from the bone marrow in atopy. We measured Lin-CD117+CD34+FceRI+ cells in the peripheral blood of 10 individuals with AD and 10 healthy controls. Flow cytometry revealed a significant increase in myeloid progenitors in participants with AD (P = .0067). Total serum IgE levels did not correlate with myeloid progenitors. To our knowledge, examination of this cell type in AD is previously unreported. Our findings suggest increased progenitor egress from the bone marrow in these patients and a possible role for myeloid progenitors in disease pathogenesis.
Keywords: Atopic dermatitis; Immunology; Mast cells; Myeloid cells; Translational medicine.
© 2025 The Authors.
Figures



Similar articles
-
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week randomized double-blind placebo-controlled phase III trial in Japan (ADhere-J).Br J Dermatol. 2025 Mar 18;192(4):597-610. doi: 10.1093/bjd/ljae394. Br J Dermatol. 2025. PMID: 39442013 Clinical Trial.
-
Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis.Br J Dermatol. 2024 Jun 20;191(1):82-91. doi: 10.1093/bjd/ljae037. Br J Dermatol. 2024. PMID: 38287887
-
Topical tacrolimus for atopic dermatitis.Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2. Cochrane Database Syst Rev. 2015. PMID: 26132597 Free PMC article.
-
Specific allergen immunotherapy for the treatment of atopic eczema.Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD008774. doi: 10.1002/14651858.CD008774.pub2. Cochrane Database Syst Rev. 2016. PMID: 26871981 Free PMC article.
-
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067. Br J Dermatol. 2024. PMID: 38367194 Clinical Trial.
References
-
- Alvarado-Vazquez P.A., Mendez-Enriquez E., Salomonsson M., Kopac P., Koren A., Bidovec-Stojkovic U., et al. Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. J Allergy Clin Immunol. 2024;153:1441–1453.e10. - PubMed
-
- Alvarado-Vazquez P.A., Mendez-Enriquez E., Salomonsson M., Waern I., Janson C., Wernersson S., et al. Circulating mast cell progenitors increase during natural birch pollen exposure in allergic asthma patients. Allergy. 2023;78:2959–2968. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials